Brief: Enorama Pharma Bioequivalence Study Shows Positive Results
20/12/2017 14:34
Dec 20 (Reuters) - ENORAMA PHARMA AB ERMA.ST :
* SHOWS POSITIVE RESULTS IN BIOEQUIVALENCE STUDY
Source text for Eikon: ID:nWkr3s7PGt
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO